Membrane-Targeting Triphenylphosphonium Functionalized Ciprofloxacin for Methicillin-Resistant Staphylococcus aureus (MRSA)

Multidrug-resistant (MDR) bacteria have become a severe problem for public health. Developing new antibiotics for MDR bacteria is difficult, from inception to the clinically approved stage. Here, we have used a new approach, modification of an antibiotic, ciprofloxacin (CFX), with triphenylphosphoni...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Sangrim, Sunwoo, Kyoung, Jung, Yuna, Hur, Junho K., Park, Ki-Ho, Kim, Jong Seung, Kim, Dokyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693559/
https://www.ncbi.nlm.nih.gov/pubmed/33143023
http://dx.doi.org/10.3390/antibiotics9110758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693559/
https://www.ncbi.nlm.nih.gov/pubmed/33143023
http://dx.doi.org/10.3390/antibiotics9110758

Ejemplares similares